WallStreetZenWallStreetZen

AnalystsChristopher James
Christopher James's Stock Forecasts

Analyst Ranking
Bottom 35%
#2991 out of 4587 analysts
Average Return
-2.5%
Win Rate
50%1 out of 2
Risk vs Reward
Poor
Good

Christopher James's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Intra Cellular Therapies IncITCI
+19.63%$18.29$21.88
2017-08-29 -
2018-08-30
Strong Buy

Christopher James Analyst Color

Get additional color on Christopher James's coverage of popular stocks

Christopher James's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Intra Cellular Therapies IncITCI
2Strong BuyN/AN/AUpgrades
7 years ago
Biocryst Pharmaceuticals IncBCRX
1Strong Buy$11.00N/AInitiates Coverage On
7 years ago
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.